Dr. Rupesh Ranjan, MD

Dr. Ranjan practices at M Health Fairview Southdale Hospital in Edina, Minnesota, part of M Health Fairview.

Dr. Ranjan's NPI, 1861766693, was assigned on February 24, 2012. Dr. Ranjan holds Minnesota license 64755.

Dr. Ranjan's primary practice is M Health Fairview Southdale Hospital, at 6401 France Avenue South, Edina, MN 55435 in Hennepin County. The practice phone is (952) 924-5000.

Dr. Ranjan's primary practice is M Health Fairview Southdale Hospital in Edina, Minnesota, part of M Health Fairview. Dr. Ranjan is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Ranjan to 3 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ranjan practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ranjan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Ranjan's licenses on file in 2 states: Minnesota and Pennsylvania.

CMS data shows 1,087 Medicare services from Dr. Ranjan across 20 procedure codes in 2024, for 664 Medicare patients. Medicare paid $55,485 for them.

CMS counts 664 Medicare patients who saw Dr. Ranjan in 2024. The largest group is 75 to 84, with 245 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ranjan's median patient age at 71, with 40% women.

In 2024, Dr. Ranjan wrote 2,238 Medicare Part D claims for 404 patients. 82% of them were for generic drugs. CMS names the drug for 2,092 of them, across 31 drugs with 11 or more claims each, at $472,540 in total drug cost. In 2023, CMS named 1,847 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Ranjan for performance year 2024, reported as part of a group. Dr. Ranjan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Ranjan, published from 2011 to 2020. 2015 was the busiest year, with 2. Dr. Ranjan's most frequent co-authors are Nelson B. Schiller, MD, Craig J. Baker, MD and Mark Lee Barr, MD.

CMS Open Payments shows 75 general payments to Dr. Ranjan from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Medtronic Vascular, Inc. paid the most, $1,387.